RxDoctor Payments Data

Timothy Whalen, MD

Psychiatry · Muscle Shoals, ALNPI 1518911999

Payments from drug & device makers

$2,539in general payments, 2019–2025

Across 175 payments — averaging $14.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$940
  • Corium, LLC$398
  • Teva Pharmaceuticals USA, Inc.$352
  • Vanda Pharmaceuticals Inc.$116
  • Supernus Pharmaceuticals, Inc.$108
  • Johnson & Johnson$98
  • plus $525 from 13 others

What the payments were for

  • Food & beverage$2,47998%
  • Education$602%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,539 in reported general payments places this provider in the 70th percentile of 400 psychiatry providers in Alabama.

See all psychiatry providers in Alabama

Medicare billing

Part B allowed, 2024
$54,222
Medicare patients
97
Services billed
657

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl67$97,747
Invega SustennaPaliperidone Palmitate21$51,611
Abilify MaintenaAripiprazole12$37,794
NuedextaDextromethorphan Hbr/Quinidine13$18,935
Fluvoxamine Maleate ErFluvoxamine Maleate18$11,129
Lurasidone Hcl31$11,003
Protriptyline Hcl22$7,696
Divalproex Sodium ErDivalproex Sodium73$6,393
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl24$5,806
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine180$5,676
Aripiprazole118$5,458
Lisdexamfetamine Dimesylate20$5,047
Vilazodone Hcl38$4,920
Bupropion XlBupropion Hcl185$4,851
Duloxetine Hcl159$3,929

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$940$97,74767 claims
Johnson & JohnsonInvega Sustenna$98$51,61121 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$16$37,79412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 400 psychiatry providers in Alabama.

Other psychiatry in Muscle Shoals

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →